Menu
Not yet recruiting NCT07286396

Non-invasive Intracranial Pressure Monitoring in Brain Tumor Patients

Observational Brain Neoplasm Intracranial Pressure Increase

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Ocular Sonography.
Who it may be relevant to
Registry conditions: Brain Neoplasm, Intracranial Pressure Increase. Basic parameters: from 21 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Non-invasive Intracranial Pressure Monitoring in Brain Tumor Patients: A Prospective Observational Study of Optic Nerve Sheath Diameter Dynamics

Overview

This research protocol focuses on the pre- and post-operative evaluation of ICP using non-invasive methods, particularly in the context of surgery for brain tumor removal. By utilizing ocular ultrasound to measure ONSD and ONSD/ETD ratios, this study hypothesizes that the utility of these parameters in monitoring ICP pre- and post-operative periods could be effective.

Detailed description

This research protocol focuses on the pre- and post-operative evaluation of ICP using non-invasive methods, particularly in the context of brain tumor resection surgery. By utilizing ocular ultrasound to measure ONSD and ONSD/ETD ratios, this study hypothesizes that the utility of these parameters in monitoring ICP pre- and post-operative periods could be effective.

This study aims to evaluate the effectiveness of the ONSD and the ONSD/ETD ratio using ultrasound as a non-invasive method for measuring intracranial pressure pre- and post-operatively in brain tumor patients.

Interventions

  • Diagnostic test Ocular Sonography
    The examination will employ an ultrasound machine with a linear probe. Patients will be positioned supine with their heads elevated at a 20-30° angle. They will be instructed to keep their eyes closed in a neutral position while suppressing voluntary eye movement.The transducer will be gently placed on the gel in the temporal region of the eyelid to avoid exerting pressure on the eye. Optic nerve sheath diameter will be measured 3 mm posterior to the optic nerve's tip, with electronic calipers u

Primary outcome measures

  • optic nerve sheath diameter dynamics [Time frame: before (in the preoperative holding area) and after the surgery (immediate, 1,2, 4, 6, and 12 hr in ICU).]

Eligibility criteria

Inclusion criteria

  • • Adult patients (>21 years) undergoing brain tumor resection surgery.
  • Preoperative imaging-confirmed diagnosis of the tumor.
  • American Society of Anesthesiologists (ASA) physical status II to IV
  • Consent to participate in the study.

Exclusion criteria

  • • Preexisting ocular conditions affecting the optic nerve or globe integrity, such as glaucoma, thyroid-associated ophthalmopathy, or other optic nerve diseases.
  • Combined ocular and optic nerve injuries at admission.
  • History of cranial trauma, prior neurosurgery, or lumbar puncture performed within 2 weeks before the measurement of optic nerve sheath diameter (ONSD).
  • History of subarachnoid hemorrhage (SAH).
  • Serious complications that could affect life expectancy, such as hematological disorders or malignancies.
  • Refusal to participate or withdrawal of consent at any stage.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Egypt · 1 center
  • Faculty of medicine, Tanta university — Tanta

Identifiers

NCT: NCT07286396 · ICP measurement

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗